Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC)
NCT03875859
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
4
Enrollment
OTHER
Sponsor class
Stopped
The available study medication reached expiry (logistics).
Conditions
Squamous Cell Carcinoma
Interventions
DRUG:
Remetinostat
Sponsor
Kavita Sarin
Collaborators
[object Object]